Eledon Pharmaceuticals
ELDN
#9039
Rank
A$0.28 B
Marketcap
A$3.51
Share price
-1.61%
Change (1 day)
-16.08%
Change (1 year)

Earnings for Eledon Pharmaceuticals (ELDN)

Earnings in 2026 (TTM): -A$0.13 Billion

According to Eledon Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.12 Billion a decrease over its 2024 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eledon Pharmaceuticals from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.13 Billion4.19%
2025 -A$0.12 Billion17.96%
2024 -A$0.11 Billion64.13%
2023 -A$61.78 Million8.09%
2022 -A$57.15 Million7.9%
2021 -A$52.97 Million127.81%
2020 -A$23.25 Million14.09%
2019 -A$20.38 Million0.88%
2018 -A$20.2 Million7.16%
2017 -A$18.85 Million-26.24%
2016 -A$25.56 Million-60.7%
2015 -A$65.03 Million92.91%
2014 -A$33.71 Million